Arya Sciences Acquisition: Doubles on deal to take Nautilus public

Nautilus Biotechnology

08/02/2021 18:50

** Shares of blank-check firm Arya Sciences Acquisition III
Corp  ARYA.O  nearly double to $22.45, among top pct gainers on
Nasdaq
    ** Co to take protein analysis company Nautilus
Biotechnology Inc public through a merger, in a deal that values
the target company at $900 mln  urn:newsml:reuters.com:*:nBw6yvBzxa
    ** Nautilus will receive $350 mln in proceeds on the deal
    ** Special purpose acquisition companies like ARYA are shell
companies which raise funds through an IPO to take a private
company public through a merger 
    ** ARYA raised $130 mln through an IPO last year  urn:newsml:reuters.com:*:nASA011DF

 (Reporting by Sohini Podder in Bengaluru)
 ((sohini.podder@thomsonreuters.com))